105 related articles for article (PubMed ID: 17194487)
1. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
Chang LL; Cheng PN; Chen JS; Young KC
Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
Kronenberger B; Herrmann E; Hofmann WP; Wedemeyer H; Sester M; Mihm U; Ghaliai T; Zeuzem S; Sarrazin C
J Leukoc Biol; 2006 Aug; 80(2):298-308. PubMed ID: 16735696
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
[TBL] [Abstract][Full Text] [Related]
4. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
[TBL] [Abstract][Full Text] [Related]
5. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
[TBL] [Abstract][Full Text] [Related]
6. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
[TBL] [Abstract][Full Text] [Related]
7. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
[TBL] [Abstract][Full Text] [Related]
8. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
9. Influence of amantadine on CD81 expression on lymphocytes in chronic hepatitis C.
Welker MW; von Wagner M; Ochs D; Zimmer V; Hofmann WP; Piiper A; Hartmann RW; Herrmann E; Zeuzem S; Kronenberger B
Dig Liver Dis; 2010 Oct; 42(10):735-40. PubMed ID: 20457015
[TBL] [Abstract][Full Text] [Related]
10. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
[TBL] [Abstract][Full Text] [Related]
12. Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha.
Wan L; Kung YJ; Lin YJ; Liao CC; Sheu JJ; Tsai Y; Lai HC; Peng CY; Tsai FJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):855-60. PubMed ID: 19118522
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
14. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
15. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.
Schott E; Witt H; Neumann K; Bergk A; Halangk J; Weich V; Müller T; Puhl G; Wiedenmann B; Berg T
J Viral Hepat; 2008 Jan; 15(1):71-8. PubMed ID: 18088248
[TBL] [Abstract][Full Text] [Related]
16. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
